NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Univercells

Univercells

Private
BelgiumHealthcare & Life Scienceshttps://univercells.com

Last Round

Grant

Oct 9, 2023

Total Funding Raised

$301.34M

Company Overview

Univercells is a biotechnology company that develops innovative biomanufacturing platforms and services to enhance the accessibility and affordability of vaccines and biotherapeutics.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Biotech Equipment, Smart Manufacturing

Business Model

B2B

Customer Profile

Hardware Sales, Services & Consulting

AI Layer

Non-AI

Keywords

biomanufacturingbioprocessingbioreactorviral vector manufacturingCDMOcontract development and manufacturing organizationgene therapy manufacturingmRNA productionbioprocess automationbiotech equipmentbioprocess monitoringadvanced therapy manufacturingbioprocessing techbiotech scale-upbiologics production

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Univercells Comparables

Compare Univercells with similar companies based on industry and business-model similarity.

Univercells comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Univercell
100%
OmniBRx Biotechnologies
85%
Danaher Corporation
79%

Univercells Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantOct 9, 2023
Series DOct 19, 2022
DebtJul 1, 2021
Series CDec 17, 2020
Corporate FundingFeb 18, 2020
Debt
Oct 3, 2019

Key People

Founding team and executive leadership

Jose Castillo

Co-Founder And CTO

Founding Team

Carol Walton

Business Development Advisor To Cofounders (CEO And CTO) To CBO

Founding Team

David Louvet

Chief Operating Officer, Chief Human Resources Officer

Executive Team

Univercells Investors

Notable investors and investment history

Univercells investors
InvestorRounds
Federal Holding and Investment CompanySeries C, Series D
Farallon Capital ManagementSeries C
Kohlberg Kravis RobertsCorporate Funding
Korea Investment PartnersSeries C, Series B
The Innovation FundSeries B
Gamma BiosciencesCorporate Funding
Société Régionale d'Investissement de WallonieSeries C, Series D

Market signals

Structured signals derived from secondary market and firmographic data.

  • Oct 9, 2023

    $20M raised from Gates Foundation.

  • Dec 17, 2020

    $86M round led by Farallon Capital Management and Federal Holding and Investment Company.

Univercells Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Univercells Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Univercells's valuation, stock price, and market status.

Firmographic Details

HeadquartersBelgium
Employee Range25
Year Founded2013
Last FundingOct 9, 2023

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.